Health
First-of-its-Kind Study Will Test Combination of Different COVID-19 Vaccines – Technology Networks
A clinical trial has launched today in the UK that will test the effects of using two different COVID-19 vaccines for dose one and dose two. The study – Comparing…
A clinical trial has launched today in the UK that will test the effects of using two different COVID-19 vaccines for dose one and dose two. The study Comparing COVID-19 Vaccine Schedule Combinations, or “Com-COV” is the first of its kind and will also explore the impact of using different dosing intervals.
The UK’s COVID-19 vaccine rollout commenced in December, and requires an individual to receive two doses of the same vaccine, either Pfizer/
BioNTech’s BNT162b2 or AstraZeneca/Oxford’s ChAdOx1,…
-
Business20 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?
-
Business19 hours ago5 things to watch on the ASX 200 on Monday 7 April 2025
-
Business16 hours ago1 ASX dividend stock down 43% I’d buy right now
-
Noosa News16 hours agoBanana farmers still salvaging fruit four weeks after ex-Tropical Cyclone Alfred